Odelle Technology is a specialist consultancy in market access, health economics, and reimbursement strategy for pharmaceuticals, biotechnology, in vitro diagnostics (IVD), digital health, and MedTech. With expertise in health technology assessment (HTA) submissions, value proposition development, and clinical coding, Odelle assists clients across the EU, UK, and USA in navigating formal and informal reimbursement pathways.

Odelle supports companies in securing reimbursement through new DRG codes (Diagnosis-Related Groups) in Europe and CPT codes (Current Procedural Terminology) in the USA, while generating real-world evidence (RWE) to strengthen market access strategies. The company collaborates with all major HTA agencies in the EU and UK, including NICE, HAS, IQWiG, ZIN, AIFA, and others, as well as with the National Institutes of Health (NIH) in the USA. By working with payers, policymakers, clinical experts, and industry leaders, Odelle ensures that innovative healthcare technologies achieve optimal reimbursement and market adoption.